Jeff Huber’s wife died of colon cancer. As the head of Grail, he is on a mission to develop a kind of blood test that could have saved her.
Easy to use. Hard to control. The intelligence community now sees CRISPR as a threat to national safety.
Researchers implanted a “stentrode” to record activity in the brains of live sheep without having to cut open their skulls.
A new class of experimental therapies is emerging from the study of how the community of microörganisms in your body contributes to disease.
Visa-free travel is a luxury allowed only between countries that share excellent relations. Now the first global map of this visa-free travel network reveals the underlying geopolitical landscape.
Fear of the Zika virus could generate support for gene drives, a radical technology able to make species go extinct.
The tiny country has announced its enthusiasm for getting into the off-world resource-extraction business. Trouble is, that business doesn’t exist yet.
Mechanical engineers have developed a new helmet design that tackles a key contributor to brain injury.
The company trying to be the first to turn the powerful gene-editing tool CRISPR into medicine faces a number of hurdles.
A state-owned chemical corporation’s $43 billion proposed acquisition reflects the country’s sizable concerns about food security.